Dai Lu

Anesthesiology

1500 Citywest Blvd Ste 300
Houston, TX 77042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Advances in the discovery of selective NaV1.8 inhibitors for pain management.

Advances in the discovery of selective NaV1.8 inhibitors for pain management.

Journal: European journal of medicinal chemistry

Published: September 17, 2025

Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation.

Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation.

Journal: ACS bio & med chem Au

Published: July 02, 2025

Evaluating critical quality attributes and novel drug release testing of difluprednate nanoemulsions.

Evaluating critical quality attributes and novel drug release testing of difluprednate nanoemulsions.

Journal: International journal of pharmaceutics

Published: December 14, 2024

Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.

Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.

Journal: PloS one

Published: April 22, 2024

Development of optimal in vitro release and permeation testing method for rectal suppositories.

Development of optimal in vitro release and permeation testing method for rectal suppositories.

Journal: International journal of pharmaceutics

Published: March 03, 2023

Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.

Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.

Journal: Cannabis and cannabinoid research

Published: January 19, 2023

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.

ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.

Journal: Cancers

Published: September 28, 2022

In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.

In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery.

Journal: Journal of pharmaceutical sciences

Published: November 20, 2021

Synthesis and pharmacological characterization of glucopyranosyl-conjugated benzyl derivatives as novel selective cytotoxic agents against colon cancer.

Synthesis and pharmacological characterization of glucopyranosyl-conjugated benzyl derivatives as novel selective cytotoxic agents against colon cancer.

Journal: Royal Society open science

Published: May 11, 2021

The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

Journal: The Journal of pharmacology and experimental therapeutics

Published: April 27, 2021

Ultra-long acting prodrug of dolutegravir and delivery system - Physicochemical, pharmacokinetic and formulation characterizations.

Ultra-long acting prodrug of dolutegravir and delivery system - Physicochemical, pharmacokinetic and formulation characterizations.

Journal: International journal of pharmaceutics

Published: March 16, 2021

Molecular Mechanism and Cannabinoid Pharmacology.

Molecular Mechanism and Cannabinoid Pharmacology.

Journal: Handbook of experimental pharmacology

Published: April 03, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026